Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
University of Pennsylvania · Cancer Research Institute of the Slovak Academy of Sciences
Abstract
Autophagy is a lysosome-dependent degradative pathway frequently activated in tumor cells treated with chemotherapy or radiation. Whether autophagy observed in treated cancer cells represents a mechanism that allows tumor cells to survive therapy or a mechanism for initiating a nonapoptotic form of programmed cell death remains controversial. To address this issue, the role of autophagy in a Myc-induced model of lymphoma generated from cells derived from p53ER(TAM)/p53ER(TAM) mice (with ER denoting estrogen receptor) was examined. Such tumors are resistant to apoptosis due to a lack of nuclear p53. Systemic administration of tamoxifen led to p53 activation and tumor regression followed by tumor recurrence.…
Citation impact
- FWCI
- 37.50
- Percentile
- 100%
- References
- 60
Authors
8Topics & keywords
- Autophagy
- ATG5
- Apoptosis
- Cancer research
- Programmed cell death
- Lysosome
- Small hairpin RNA
- Cancer cell
- Good health and well-being